A special focus on cancer immunotherapy.  

Sign Up Now

Home
iOnco Analytics is a subdivision of VacZine Analytics a world leading supplier of vaccine market analyses.

iOnco Analytics provides a suite of commercial analysis products focused on new transformative T-cell immunotherapies.

Our role is to define market potential and strategy of new interventions in this space.

Latest Research
CAR-T multiple myeloma global market forecast Q4 '17 (SOON!)
CAR-T r/r CLL global market forecast October '17 (NEW!)
CAR-T r/r B-cell NHL global market forecast August '17 (NEW!)
CAR-T r/r B-ALL global market forecast May '17
CAR-T therapy overview Mar '17
Therapeutic cancer vaccines Feb '17
HPV therapeutic vaccines Dec '16
Melanoma vaccines June '11

Latest Articles/Snapshots
CAR-T for r/r CLL - the next logical step?
Summary of recent Bluebird Bio CAR-T/IO business alliances (October 2017)
Summary of recent Cellectis CAR-T/IO business alliances (September 2017)
Summary of recent Celyad CAR-T/IO business alliances (August 2017)
Summary of recent Juno Therapeutics CAR-T/IO business alliances (August 2017)
Summary of recent Kite Pharma CAR-T/IO business alliances (August 2017)
Summary of recent Novartis CAR-T/IO business alliances (July 2017)
Novel CAR-T therapies: it can't be ALL about price
Conference report: Third International Symposium on Immunotherapy, ICVI (London)
Vaccines in the Trump era
Latest News

© 2017 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. We sponsor Group B Strep Support.